Showing results (21-30 of 161) with videos related to
Sort By:
Pageof 17
Klinische Padiatrie|July 1, 1996
[IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study]G Fleischhack, N Graf, C Hasan, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2001
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patientsG Fleischhack, M Schmidt-Niemann, B Wulff, et al.The Journal of Antimicrobial Chemotherapy|June 5, 2001
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancerG Fleischhack, C Hartmann, A Simon, et al.Klinische Padiatrie|October 21, 2011
Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitalsT Krenn, G Fleischhack, O Moser, et al.British Journal of Cancer|January 26, 2005
Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failureS Buchen, D Ngampolo, R G Melton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2007
Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumorsM Benesch, M Windelberg, W Sauseng, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 6, 2007
Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter surveyA Simon, T Lehrnbecher, U Bode, et al.Journal of Neuro-Oncology|September 3, 2014
Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trialU Bode, M Zimmermann, O Moser, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1986
Methotrexate as relapse therapy for rhabdomyosarcomaU BodeKlinische Padiatrie|September 29, 2001
[Surveillance for nosocomial infections in pediatric hematology/oncology patients]A Simon, G FleischhackPageof 17